Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1081
Structure model predictions of wildtype and A398E/V and M1425V/I Ca<sub>V</sub>3.3 channels.
Published 2025Subjects: -
1082
-
1083
-
1084
-
1085
-
1086
<i>Cdkl5</i> -/Y mice show an increased freezing time and a decreased distance traveled during the pretone period in the altered context.
Published 2018“…<i>Cdkl5</i> -/Y mice show a significantly decreased distance traveled in response to the first footshock (p = 0.0158) compared with control mice. …”
-
1087
-
1088
Experiment 1: Comparison of effort and delay discounting.
Published 2015“…The sigmoidal model was included because it fulfills two particular features: it can obtain initially concave shapes, in line with work showing that the sense of effort increases as a power function of the target force with decreasing sensitivity at lower effort levels; and it entails a turning point after which effort discounting becomes progressively less steep. …”
-
1089
-
1090
-
1091
-
1092
-
1093
-
1094
Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx
Published 2022“…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”
-
1095
-
1096
-
1097
(R+S) and (R)-albuterol decrease NF-κB activity
Published 2011“…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”
-
1098
-
1099
-
1100